Asthma Control Study

NCT03304067 | Completed

• 1 other identifier: EH-005
• Study Type: interventional
• Target: 262
• Locations: 1 country
• Sites: 1

Brief Summary

The "Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores" Study is a 16 week, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Tueo Health program on asthma control as indicated by change in baseline and study end (week 16) score on the Childhood Asthma Control Test score (ages 6- under 12 years) and the Asthma Control Test (ages 12-17 years) in children with uncontrolled asthma as the primary study objective.

Conditions

Childhood Asthma

Outcome Measures

Primary Outcomes (1)

• Change in ACT/C-ACT scores

  Change in ACT/C-ACT scores from baseline to study end

  Baseline and Week 16

Study Arms (2)

Intervention

EXPERIMENTAL

Behavioral: Tueo Program

Control

NO INTERVENTION

Interventions

Tueo Program BEHAVIORAL

The asthma management solution utilizes devices (2 to attach on the child's bed and 1 for data transmission), which collect various metrics for a tailored smartphone application experience. The smartphone application provides access to view metrics from the devices, educational and clinical context content, and an asthma coach.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Parent has a child who is \> 6 and \< 17.5 years old
• Parent reports child has a diagnosis of asthma
• Child takes daily asthma controller medication
• Child has used rescue inhaler (e.g.albuterol, ProAir, etc) or nebulizer at least 2 times per week in the past 4 weeks
• Child sleeps on a toddler, single, or double bed by themselves
• Child will live in the same home for the majority of the next 16 weeks
• Parent is \> 18 years old

You may not qualify if:

• Child's asthma has been controlled over the past 4 weeks
• Child has any of the following conditions: sleep apnea, congenital heart disease, cardiac arrhythmias, or any other heart abnormalities, neurologic conditions including seizures, cerebral palsy, muscular dystrophy, genetic conditions or developmental disorders, autism, other major medical condition
• Child is currently pregnant
• Child was born premature (earlier than 36 weeks)
• Parent is not fluent in English
• No in-home WiFi
• Parent does not use an Android phone as their primary phone
• In a household with an existing enrolled participant in the study, even for a different child (e.g. only one child in a household may have questions reported back to the researchers by their parent)
• Lives in Hawaii or Alaska

Sponsors & Collaborators

• Evidation Health: lead
• Tueo Health: collaborator

Study Sites (1)

Evidation Health

San Mateo, California, 94401, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 2, 2017
• First Posted: October 6, 2017
• Study Start: October 3, 2017
• Primary Completion: May 3, 2018
• Study Completion: May 3, 2018
• Last Updated: July 17, 2018

Record last verified: 2018-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)